Vice President, Corporate Development

Role Summary

The Vice President, Corporate Development informs and executes the company’s M&A growth strategy. The role leads the company’s strategic transactions, including acquisitions, new technology licenses, and collaborations, and partners with cross-functional teams to drive value creation.

Responsibilities

• Develop and drive corporate M&A strategy
• Works independently and in collaboration with internal groups to provide detailed economic analyses of new opportunities (e.g., market research, business intelligence, competitive analysis, development plan, commercial forecast, NPV analyses) to inform business decisions
• Presents business rationale, analyses, and proposals to senior executives
• Coordinates the evaluation and diligence of new opportunities endorsed by the Strategic Investment Counsel across multiple functional areas including Research, Clinical, Regulatory, Commercial, Manufacturing, Finance, Legal, Intellectual Property and other groups
• Develops deal concepts and negotiates term sheets, deal structure, and definitive agreements in collaboration with corporate legal and finance groups
• Drives the deal process from first contact with potential partners to execution of agreements
• Establishes an extensive network of strong and trusting relationships with prospective targets, advisors, and industry investors with the goal of expanding the external perception of Halozyme as a partner of choice

Qualifications

• Minimum of Advanced degree in Life Sciences or MBA with minimum of 15 years of relevant experience in biotech or pharmaceutical industry (An equivalent combination of experience and education may be considered)
• Proven track record of accomplishing Corporate Development goal objectives through deal sourcing, due diligence, licensing, and M&A execution
• Extensive in-pharma Corporate Development experience
• Strong analytical and financial acumen
• Deep understanding of drug or product development, regulatory pathways, and commercial strategy to evaluate opportunities beyond financial analysis
• Experienced leadership in managing cross-functional teams across R&D, legal, finance, and commercial functions
• Proven experience identifying, leading, and executing a minimum of three end-to-end M&A transactions totaling approximately $1–2 billion in aggregate valuation over 2–3 years